Selected Publications:
1. Wilding G. Endocrine control of prostate cancer. Cancer Surveys 1995, 23: 43-62.
2. Thompson TA, Wilding G. Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells. Mol. Cancer Ther. 2003;2(8):797-803.
3. Basu HS, Thompson TA, Clower C, Church D, Mehraein F, Amlong C, Madapathage T, Woster P and Wilding G. An inhibitor of acetyl polyamine oxidase specifically blocks androgen induced oxidative stress and prevents occurrence of prostate cancer in TRangenic Adenocarcinoma of Mouse. Abstract Prostate (TRAMP). Abstract presented at the 18th Annual EORTC-AACR-NCI Conference on Molecular Targets and Cancer Therapeutics, Nov. 2006, Prague, Czech Republic
4. N, Afaq F, Mukhtar H. Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise. Antioxid Redox Signal. 2007 Dec 21; [Epub ahead of print]
5. M, Kweon MH, Yun JM, Adhami VM, Khan N, Syed DN, Mukhtar H. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res. 2005 Dec 1;65(23):11203-13.
6, M, Kaur S, Kweon MH, Adhami VM, Afaq F, Mukhtar H. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Carcinogenesis. 2005 Nov;26(11):1956-64. Epub 2005 Jun 15.
7. M, Afaq F, Adhami VM, Mukhtar H. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene. 2004 Jul 1;23(30):5203-14.
